Cognizant® Shared Investigator Platform (SIP)
is the industry’s first cloud-based single-instance multi-tenant solution that offers broad capabilities across the lifecycle of a clinical trial from site selection and study execution all the way to study closeout.
Developed in close partnership with trial sponsors and research sites, Cognizant SIP unites investigators and sponsors and allows them to work together virtually, anytime, anywhere. Providing a single point of access and a central workspace, the platform accelerates key clinical trial processes and reduces the administrative burden on investigators, which helps enable faster time to market for new therapies and more time for patient care.
Through its single sign-on capability, Cognizant SIP reduces the need to log into multiple portals or applications and brings together best-of-breed technologies from an ecosystem of partners to streamline collaboration for trial sponsors, CROs, site investigators, and clinical researchers.
Cognizant SIP helps sponsors accurately report safety notifications as per local regulations by setting up automated global and country distribution rules. The platform helps sponsors reduce redundant training for sites by recognizing over 1,900 Mutually-Recognized Training (MRT) courses that have been completed by sites.